Julien Péron

19PUBLICATIONS
60CO-AUTHORS
Counselling, wellbeing and community servicesRehabilitationApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Sep 03, 2026
Patient-Centered Clinical Decision Support for Recommended Screenings in French Primary Care: Protocol for a Multicenter Mixed Methods Feasibility Study.

|Jul 28, 2026
Realist Collaborative Evaluation of a Work Disability Prevention Program for Breast Cancer Survivors: Protocol for a RECOVA-FASTRACS Realist Evaluation.

|Jul 28, 2026
Patients with Cancer and Immune Checkpoint Inhibitor-Induced Rheumatic irAEs Treated by DMARDs: The RHUMICI Single-Centre Retrospective Cohort.

|May 31, 2024
Intraperitoneal Nivolumab after Debulking Surgery and Hyperthermic Intraperitoneal Chemotherapy in Advanced Ovarian Cancer: A Phase I Study with Expansion Cohort.

Pauline Corbaux, Gilles Freyer, Olivier Glehen

|Jan 21, 2023
Impact of Liver Metastases and Number of Metastatic Sites on Immune-Checkpoint Inhibitors Efficacy in Patients with Different Solid Tumors: A Retrospective Study.

Madeleine Maugeais, Julien Péron, Stéphane Dalle

|Jan 04, 2023
Individualized Net Benefit estimation and meta-analysis using generalized pairwise comparisons in N-of-1 trials.

Joris Giai, Julien Péron, Matthieu Roustit

Pageof 4

Frequent Collaborators

4 joint publications

Pauline Corbaux

4 joint publications

Thibaut Reverdy

2 joint publications

Vahan Kepenekian

2 joint publications

Cyrille B Confavreux